3 RAG1/2 introduces double-stranded breaks at non-Ig loci | 75 35. Roberts KG. Genetics and prognosis of ALL in children vs adults. Hematol Am Soc Hematol Educ Progr. 2018;2018(1):137-145. doi:10.1182/asheducation-2018.1.137 36. Jain N, Roberts KG, Jabbour E, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129(5):572581. doi:10.1182/blood-2016-07-726588 37. Kharas MG, Yusuf I, Scarfone VM, et al. KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood. 2007;109(2):747-755. doi:10.1182/blood-2006-03-011106 38. Rohil Y, Shetty D, Narula G, Banavali SD. A Novel Case of ABL2 Chromosomal Rearrangement in High-Risk B-Cell Acute Lymphoblastic Leukemia. J Assoc Genet Technol. 2019;45(2):73-76. 39. Volodko N, Gordon M, Salla M, Ghazaleh HA, Baksh S. RASSF tumor suppressor gene family: biological functions and regulation. FEBS Lett. 2014;588(16):2671-2684. doi:10.1016/j.febslet.2014.02.041 40. Bridges AE, Ramachandran S, Pathania R, et al. RAD51AP1 Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-Renewal. Cancer Res. 2020;80(18):3855-3866. doi:10.1158/0008-5472.CAN-19-3713 41. Wang B, Guo H, Yu H, Chen Y, Xu H, Zhao G. The Role of the Transcription Factor EGR1 in Cancer. Front Oncol. 2021;11:642547. doi:10.3389/fonc.2021.642547 42. Paigen K, Petkov PM. PRDM9 and Its Role in Genetic Recombination. Trends Genet. 2018;34(4):291-300. doi:10.1016/j. tig.2017.12.017 43. Deng YN, Xia Z, Zhang P, Ejaz S, Liang S. Transcription Factor RREB1: from Target Genes towards Biological Functions. Int J Biol Sci. 2020;16(8):1463-1473. doi:10.7150/ ijbs.40834 44. Wang T, Zhu X, Wang K, et al. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3. Pulm Pharmacol Ther. 2023;80:102217. doi:10.1016/j. pupt.2023.102217 45. Keskin N, Deniz E, Eryilmaz J, et al. PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function. Mol Cell Biol. 2015;35(10):1741-1753. doi:10.1128/ MCB.01475-14 46. Chuang JY, Wu CH, Lai MD, Chang WC, Hung JJ. Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int J cancer. 2009;125(9):2066-2076. doi:10.1002/ ijc.24563 47. Yusuf I, Kharas MG, Chen J, et al. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol. 2008;20(5):671681. doi:10.1093/intimm/dxn024 48. Zhao J, Bacolla A, Wang G, Vasquez KM. Non-B DNA structure-induced genetic instability and evolution. Cell Mol Life Sci. 2010;67(1):43-62. doi:10.1007/s00018-0090131-2 49. Xu Q, Kowalski J. NBBC: a non-B DNA burden explorer in cancer. Nucleic Acids Res. 2023;51(W1):W357-W364. doi:10.1093/ nar/gkad379 50. Naik AK, Lieber MR, Raghavan SC. Cytosines, but not purines, determine recombination activating gene (RAG)-induced breaks on heteroduplex DNA structures: implications for genomic instability. J Biol Chem. 2010;285(10):7587-7597. doi:10.1074/jbc. M109.089631 51. Posey JE, Pytlos MJ, Sinden RR, Roth DB. Target DNA structure plays a critical role in RAG transposition. PLoS Biol. 2006;4(11):e350. doi:10.1371/journal. pbio.0040350 52. Tsai CL, Chatterji M, Schatz DG. DNA mismatches and GC-rich motifs target transposition by the RAG1/RAG2 transposase. Nucleic Acids Res. 2003;31(21):6180-6190. doi:10.1093/ nar/gkg819 53. Ji Y, Resch W, Corbett E, Yamane A, Casellas R, Schatz DG. The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci. Cell. 2010;141(3):419-431. doi:10.1016/j. cell.2010.03.010 54. Vettermann C, Schlissel MS. Allelic exclusion of immunoglobulin genes: models and mechanisms. Immunol Rev. 2010;237(1):2242. doi:10.1111/j.1600-065X.2010.00935.x
RkJQdWJsaXNoZXIy MTk4NDMw